Evidence map›Paper›PMID 38049811›Full record

ArticleBMC medical genomics2023

Key m

Yixi Zhang, Can Qi, Yiwen Guo, Xuefeng Li, Zebin Zhu

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yixi Zhang *Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, NO. 95 Yongan Road, Beijing, 100051, China.
Can Qi *Organ Transplant Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, NO.17 Lujiang Road, Hefei, 230001, Anhui, China.
Yiwen Guo *Organ Transplant Centre, The First Affiliated Hospital, Sun Yat-sen University, NO. 58 Zhongshan Er Road, Guangzhou, 510080, Guangdong, China.
Xuefeng LiOrgan Transplant Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, NO.17 Lujiang Road, Hefei, 230001, Anhui, China.
Zebin ZhuOrgan Transplant Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, NO.17 Lujiang Road, Hefei, 230001, Anhui, China. 18826431159@163.com.
University of Science and Technology of China · CNCapital Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundN

methodsThe gene expression data (GSE23649) of m

resultsThe expressions of WTAP, CBLL1, RBM15, and YTHDC1 were found to be increased in liver tissues 2 h after portal vein perfusion; in contrast, the expressions of LRPPRC, FTO, METTL3, and ALKBH5 were decreased. Based on RF model, we identified eight m

conclusionsThe m

Indexed as

LiverReperfusion InjuryAlpha-Ketoglutarate-Dependent Dioxygenase FTOAnimalsHumansMacrophagesMethylationMethyltransferasesMiceRNA, MessengerUbiquitin-Protein LigasesAlpha-Ketoglutarate-Dependent Dioxygenase FTOCBLL1 protein, humanFTO protein, humanMethyltransferasesMETTL3 protein, humanRNA, MessengerUbiquitin-Protein LigasesHepatic ischemia-reperfusion injurym6A methylation regulatorsMETTL3YTHDC1

Identifiers

PMID38049811
PMCPMC10694893
OpenAlexW4389306982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.